Scienture Holdings Employees

As of December 31, 2024, Scienture Holdings had 19 total employees, including 14 full-time and 5 part-time employees. The number of employees did not change compared to the previous year.

Employees

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

$34,389

Profits / Employee

-$1,081,824

Market Cap

20.72M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	19	0	-
Dec 31, 2023	19	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

SCNX News

10 days ago - SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA - GlobeNewsWire
22 days ago - SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium - GlobeNewsWire
23 days ago - Scienture Holdings, Inc. (SCNX) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript - Seeking Alpha
4 weeks ago - SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9–10, 2025 - GlobeNewsWire
7 weeks ago - SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update - GlobeNewsWire
2 months ago - SCIENTURE Announces Addition of Arbli™ (Losartan Potassium) to Formularies of Major National Health Plans - GlobeNewsWire
2 months ago - SCIENTURE Announces Start of Commercial Sales and Fulfillment of First Orders for Arbli™ (Losartan Potassium) - GlobeNewsWire
2 months ago - SCIENTURE'S Arbli™ Becomes First FDA-Approved Ready-to-Use Liquid Losartan Available Through Major U.S. Wholesalers - GlobeNewsWire

More News